Correlation Between Annexon and Cullinan Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Annexon and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annexon and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Annexon and Cullinan Oncology LLC, you can compare the effects of market volatilities on Annexon and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annexon with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annexon and Cullinan Oncology.

Diversification Opportunities for Annexon and Cullinan Oncology

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Annexon and Cullinan is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Annexon and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Annexon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annexon are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Annexon i.e., Annexon and Cullinan Oncology go up and down completely randomly.

Pair Corralation between Annexon and Cullinan Oncology

Given the investment horizon of 90 days Annexon is expected to under-perform the Cullinan Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Annexon is 1.23 times less risky than Cullinan Oncology. The stock trades about -0.43 of its potential returns per unit of risk. The Cullinan Oncology LLC is currently generating about -0.15 of returns per unit of risk over similar time horizon. If you would invest  1,555  in Cullinan Oncology LLC on September 1, 2024 and sell it today you would lose (210.00) from holding Cullinan Oncology LLC or give up 13.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Annexon  vs.  Cullinan Oncology LLC

 Performance 
       Timeline  
Annexon 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Annexon are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Annexon is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Cullinan Oncology LLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cullinan Oncology LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Annexon and Cullinan Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Annexon and Cullinan Oncology

The main advantage of trading using opposite Annexon and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annexon position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.
The idea behind Annexon and Cullinan Oncology LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
FinTech Suite
Use AI to screen and filter profitable investment opportunities